Venture Capital Investors

Quaker Partners

VC investing group Quaker Partners invests in high-potential tech companies.

Venture Investor Overview

Venture Investor
Quaker Partners
Status
Active
Investor Type
Venture Capital
Activity Level
93 transactions
Funds Raised
Unknown
Industry Focus
Artificial Intelligence

Contact Information

Contact
Ira Lubert
Title
Managing Partner
Mailing Address
150 Monument Rd. 207
Bala Cynwyd, PA 19004
USA
Phone
(215) 988-6800
Website
www.quakerpartners.com
Email Address
[email protected]

Background Information

Overview
The firm leads investments in companies across the spectrum of the life science industry, including biopharmaceuticals, Medical Devices & Instruments, human diagnostics, health information technology, and healthcare services. Quaker Partners invests in companies at varying stages of development, from early stage businesses to public companies.
Profile
Quaker Partners LinkedIn Company Profile
Social Media
Quaker Partners Company Twitter Account
Company News
Quaker Partners News
Facebook
Quaker Partners on Facebook
YouTube
Quaker Partners on YouTube
Last Transaction
3/19/2024

Transaction History

Our records indicate that Quaker Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Lumino
3/19/2024
$2,800,000
Gridwise
2/28/2020
$3,300,000
Vesper Medical
5/30/2019
$37,000,000
Intact Vascular
5/30/2019
$25,000,000
Kaarta
3/22/2019
$6,500,000
StayTuned
2/21/2019
$2,500,000
Rapid Micro Biosystems
5/3/2018
$60,000,000
Rapid Micro Biosystems
6/30/2015
$18,680,100
Intact Vascular
5/15/2015
$38,900,000
Rapid Micro Biosystems
4/16/2014
$6,001,413
Tarsa Therapeutics
3/31/2014
$1,235,000
TELA Bio
9/30/2013
$6,000,000
Rapid Micro Biosystems
6/26/2013
$32,600,000
RainDance Technologies
4/29/2013
$20,000,000
Regado Biosciences
12/20/2012
$51,000,000
Intact Vascular
9/6/2012
$15,500,000
Tarsa Therapeutics
3/19/2012
$28,000,000
Celator Pharmaceuticals
12/31/2011
$2,577,000
NovaSom
6/27/2011
$35,000,000
Neuronetics
5/16/2011
$30,000,000
RainDance Technologies
1/25/2011
$37,500,000
TetraLogic Pharmaceuticals
1/5/2011
$23,000,000
Semprae Laboratories
12/30/2010
$6,099,900
Celator Pharmaceuticals
9/1/2010
$20,000,000
TetraLogic Pharmaceuticals
8/11/2010
$32,000,000
Cempra
6/30/2010
$20,499,900
Corridor Pharmaceuticals
6/30/2010
$14,475,000
Precision Therapeutics
6/11/2010
$35,000,000
TearScience
5/5/2010
$44,500,000
Semprae Laboratories
3/31/2010
$3,106,000
Neotropix
3/31/2010
$700,000
Tarsa Therapeutics
3/31/2010
$4,000,000
BioLeap
1/12/2010
$5,000,000
Regado Biosciences
12/17/2009
$40,000,000
Tarsa Therapeutics
10/21/2009
$24,000,000
TransEnterix
10/7/2009
$55,000,000
Corridor Pharmaceuticals
10/2/2009
$10,750,000
NovaSom
9/22/2009
$20,000,000
Rapid Micro Biosystems
7/8/2009
$18,600,000
Neotropix
6/30/2009
$1,400,000
Cempra
5/14/2009
$46,000,000
Optherion
3/31/2009
$5,000,000
Argolyn Bioscience
3/31/2009
$2,000,000
Neotropix
12/31/2008
$2,072,000
Tengion
11/19/2008
$21,000,000
Precision Therapeutics
11/10/2008
$43,000,000
Corridor Pharmaceuticals
10/23/2008
$2,300,000
Biolex
10/6/2008
$60,000,000
Semprae Laboratories
9/30/2008
$8,500,000
Nucleonics
9/30/2008
$116,000
Oceana Therapeutics
9/29/2008
Unknown
Celator Pharmaceuticals
7/29/2008
$22,500,000
NuPathe
7/24/2008
$30,000,000
Tier One Pharma
6/30/2008
$3,000,000
Diasome Pharmaceuticals
4/15/2008
Unknown
TargetRx
4/7/2008
$9,600,000
StageMark
3/31/2008
$85,000
EKR Therapeutics
3/10/2008
$145,000,000
Tranzyme Pharma
11/1/2007
$20,000,000
Tengion
10/15/2007
$33,000,000
Optherion
10/9/2007
$37,000,000
EKR Therapeutics
8/15/2007
$13,000,000
Celator Pharmaceuticals
8/2/2007
$10,000,000
Argolyn Bioscience
6/25/2007
$15,800,000
Biolex
5/24/2007
$30,000,000
StageMark
4/13/2007
$1,600,000
Regado Biosciences
3/27/2007
$23,000,000
Kolis Scientific
1/19/2007
$15,000,000
Neuronetics
9/30/2006
$35,000,200
Amicus Therapeutics
9/14/2006
$60,000,000
NuPathe
9/13/2006
$15,000,000
Transport Pharmaceuticals
7/31/2006
$12,600,000
Tengion
6/26/2006
$50,000,000
TetraLogic Pharmaceuticals
6/12/2006
$36,000,000
Theranox
4/10/2006
$14,000,000
Tranzyme Pharma
3/31/2006
$10,000,000
Neotropix
3/31/2006
$3,800,100
Precision Therapeutics
2/21/2006
$20,000,000
Amicus Therapeutics
9/8/2005
$55,000,000
Biolex
9/1/2005
$36,000,000
Regado Biosciences
8/12/2005
$20,000,000
Immune Control
7/14/2005
$11,300,000
Neotropix
6/30/2005
$3,800,000
Nucleonics
6/30/2005
$6,000,000
Tranzyme Pharma
5/13/2005
$32,000,000
Celator Pharmaceuticals
5/3/2005
$40,000,000
TargetRx
4/22/2005
$15,000,000
Neotropix
12/13/2004
$10,000,000
Transport Pharmaceuticals
11/22/2004
$27,000,000
Nucleonics
6/20/2004
$49,200,000
EXIMIAS Pharmaceutical
3/31/2004
$63,500,000
BioRexis Pharmaceutical
3/11/2004
$30,000,000
Biolex
8/20/2003
$24,400,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Brenda Gavin
  Brenda Gavin LinkedIn Profile  Brenda Gavin Twitter Account  Brenda Gavin News  Brenda Gavin on Facebook
Partner
Richard Kollender
  Richard Kollender LinkedIn Profile  Richard Kollender Twitter Account  Richard Kollender News  Richard Kollender on Facebook
Partner
Ira Lubert
  Ira Lubert LinkedIn Profile  Ira Lubert Twitter Account  Ira Lubert News  Ira Lubert on Facebook
Partner
Sherrill Neff
  Sherrill Neff LinkedIn Profile  Sherrill Neff Twitter Account  Sherrill Neff News  Sherrill Neff on Facebook
Partner
Adele Oliva
  Adele Oliva LinkedIn Profile  Adele Oliva Twitter Account  Adele Oliva News  Adele Oliva on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Quaker Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Amicus Therapeutics
Argolyn Bioscience
BioLeap
Biolex
BioRexis Pharmaceutical
Celator Pharmaceuticals
Cempra
Corridor Pharmaceuticals
Diasome Pharmaceuticals
EKR Therapeutics
EXIMIAS Pharmaceutical
Gridwise
Immune Control
Intact Vascular
Kaarta
Kolis Scientific
Lumino
Neotropix
Neuronetics
NovaSom
Nucleonics
NuPathe
Oceana Therapeutics
Optherion
Precision Therapeutics
RainDance Technologies
Rapid Micro Biosystems
Regado Biosciences
Semprae Laboratories
StageMark
StayTuned
TargetRx
Tarsa Therapeutics
TearScience
TELA Bio
Tengion
TetraLogic Pharmaceuticals
Theranox
Tier One Pharma
TransEnterix
Transport Pharmaceuticals
Tranzyme Pharma
Vesper Medical

 

 

 

 

Browse more venture capital investors:

Quaestus Capital Management | Qualgro Asean Fund

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.